SGLT2 Inhibitors Explained: Benefits, Risks & Who Should Take Them

Описание: SGLT2 inhibitors such as dapagliflozin, canagliflozin and empagliflozin are transforming the way we treat type 2 diabetes, heart disease, and kidney disease.

In this video, GP Dr David Stokes explains:

– What SGLT2 inhibitors do
– Who should consider taking them
– The key benefits for heart and kidney health
– Side effects and important safety warnings
– Sick day rules and when to stop the medication

These medications can be extremely effective—but they need to be used safely and appropriately.

If you’re considering starting one, or have recently been prescribed one, this video will help you understand what to expect.

Sick Day rules: it is vital if you are taking certain medicines and you develop a sickness or diarrhoea bug that you should stop certain medications, further advice can be found here:
https://www.nottsapc.nhs.uk/media/d01...

#diabetes #hearthealth #kidneydisease #longevity